SCHEMBL26847325

SCHEMBL26847325

Cc1cc(CSc2[nH]c(=O)cc(C(F)(F)F)c2C#N)on1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.56
▸ ALDH1A1 P00352 11/20 0.48
▸ MAPT P10636 2/20 0.48
▸ TSHR P16473 1/20 0.42
▸ HPGD P15428 7/20 0.41
▸ GAA P10253 6/20 0.41
▸ GLA P06280 5/20 0.41
▸ TP53 P04637 2/20 0.41
▸ KMT2A Q03164 5/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HTT P42858 3/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ HSD17B10 Q99714 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ BRCA1 P38398 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ PKM P14618 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087891 0.87 KDM4E (0.58) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL26847323 0.81 KDM4E (0.35) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL26847318 0.80 HSD11B1 (0.35) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL26847297 0.77 ALDH1A1 (0.44) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL26847326 0.76 KDM4E (0.59) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL20340034 0.75 KDM4E (0.55) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL20339496 0.75 KDM4E (0.70) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL24087955 0.75 KDM4E (0.57) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL20339450 0.73 KDM4E (0.58) KDM4EALDH1A1MAPTTSHRHPGD
SCHEMBL20339861 0.73 KDM4E (0.60) KDM4EALDH1A1MAPTTSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885MAPT 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback